Mild Cognitive Impairment

Mild Cognitive Impairment (MCI) marks a critical stage preceding Alzheimer's Disease and other types of dementia. It involves subtle changes in cognitive functions like memory and reasoning that exceed normal age-related decline. While individuals with MCI may struggle with remembering recent events or making decisions, these challenges typically do not significantly disrupt daily life.

Understanding MCI's significance lies in its potential progression to dementia, although this progression isn't inevitable. Some individuals with MCI remain stable or may even show improvement over time. Early detection and intervention are vital, as lifestyle adjustments, cognitive training, and certain medications could potentially slow down or manage further cognitive decline.

Ongoing research aims to deepen our understanding of MCI's origins, risk factors, and effective interventions, with the goal of improving outcomes and enhancing the quality of life for individuals at risk of developing dementia.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Tags
Facebook
Watsapp